日本語English简体中文 繁體中文

7776 CellSeed Inc.セルシードTSE Growth / Precision Instruments

0 posts

CellSeed Inc. (7776) at a glance

Code
7776
Company
CellSeed Inc.
Local name
セルシード
Market
TSE Growth
Sector
Precision Instruments
Share price
¥153 -2.0 (-1.29%) Nov 19 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

CellSeed Inc. (7776) Stock Price HistoryNear a 52-week low

CellSeed Inc. closed at ¥153 on Nov 19, 2026, −23.9% over 1 month, −59.7% over 1 year.

2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結) / 業績予想修正に関するお知らせ / 第24回新株予約権(行使価額修正条項付)の行使により調達した資金の充当完了に関す…¥201¥153Oct 19Nov 19
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥201Oct 19
1-Month Low¥153Nov 19
1-Week Change−9.5%vs Nov 12
1-Month Change−23.9%vs Oct 19

If you had invested ¥100,000 1 month ago, it would be worth ¥76,119 today (−23.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −8.4%, while this stock moved −23.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 19 (Thu)¥153−2−1.29%
Nov 17 (Tue)¥155−7−4.32%
Nov 16 (Mon)¥162−7−4.14%
Nov 13 (Fri)¥169+0+0.00%
Nov 12 (Thu)¥169−2−1.17%
Nov 11 (Wed)¥171−3−1.72%
Nov 10 (Tue)¥174+9+5.45%
Nov 9 (Mon)¥165+5+3.13%
Nov 6 (Fri)¥160−12−6.98%
Nov 5 (Thu)¥172−9−4.97%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結) / 業績予想修正に関するお知らせ / 第24回新株予約権(行使価額修正条項付)の行使により調達した資金の充当完了に関す…¥236¥153Aug 19Nov 19
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥236Aug 28
3-Month Low¥153Nov 19
1-Month Change−23.9%vs Oct 19
3-Month Change−32.3%vs Aug 19

If you had invested ¥100,000 3 months ago, it would be worth ¥67,699 today (−32.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −9.0%, while this stock moved −32.3%.

Last 10 Trading Days

DateCloseChange% Change
Nov 19 (Thu)¥153−2−1.29%
Nov 17 (Tue)¥155−7−4.32%
Nov 16 (Mon)¥162−7−4.14%
Nov 13 (Fri)¥169+0+0.00%
Nov 12 (Thu)¥169−2−1.17%
Nov 11 (Wed)¥171−3−1.72%
Nov 10 (Tue)¥174+9+5.45%
Nov 9 (Mon)¥165+5+3.13%
Nov 6 (Fri)¥160−12−6.98%
Nov 5 (Thu)¥172−9−4.97%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結) / 業績予想修正に関するお知らせ / 第24回新株予約権(行使価額修正条項付)の行使により調達した資金の充当完了に関す…¥264¥153May 19Nov 19
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥264May 21
6-Month Low¥153Nov 19
3-Month Change−32.3%vs Aug 19
6-Month Change−40.0%vs May 19

If you had invested ¥100,000 6 months ago, it would be worth ¥60,000 today (−40.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −1.8%, while this stock moved −40.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥153−18.6%
Oct 2026¥188−16.1%
Sep 2026¥224−4.3%
Aug 2026¥234+6.8%
Jul 2026¥219+1.4%
Jun 2026¥216−13.9%
May 2026¥251−6.7%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結) / 業績予想修正に関するお知らせ / 第24回新株予約権(行使価額修正条項付)の行使により調達した資金の充当完了に関す…¥380¥153Nov 19Nov 19
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥380Nov 19
52-Week Low¥153Nov 19
Year to Date−40.9%vs Dec 30
From 52-Week High−59.7%Nov 19

If you had invested ¥100,000 1 year ago, it would be worth ¥40,263 today (−59.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +22.5%, while this stock moved −59.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥153−18.6%
Oct 2026¥188−16.1%
Sep 2026¥224−4.3%
Aug 2026¥234+6.8%
Jul 2026¥219+1.4%
Jun 2026¥216−13.9%
May 2026¥251−6.7%
Apr 2026¥269−7.9%
Mar 2026¥292−21.1%
Feb 2026¥370+17.5%
Jan 2026¥315+21.6%
Dec 2025¥259−16.7%
Nov 2025¥311―
¥879¥153Nov 20, 2023Nov 19, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥879Aug 26, 2024
3-Year Low¥153Nov 19, 2026
Annualized Return−21.3%
Max Drawdown−82.6%

If you had invested ¥100,000 3 years ago, it would be worth ¥48,726 today (−51.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +76.8%, while this stock moved −51.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥153−40.9%
2025¥259―
¥977¥131Nov 22, 2021Nov 19, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥977Mar 20, 2023
5-Year Low¥131May 23, 2022
Annualized Return−7.2%
Max Drawdown−84.3%

If you had invested ¥100,000 5 years ago, it would be worth ¥68,919 today (−31.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +106.8%, while this stock moved −31.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥153−40.9%
2025¥259―
¥3,045¥134Apr 1, 2010Nov 19, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥3,045May 2013
All-Time Low¥134May 2022
Total Change−88.1%vs Apr 2010
Annualized Return−12.0%

If you had invested ¥100,000 in Apr 2010, it would be worth ¥11,916 today (−88.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +533.6%, while this stock moved −88.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥153−40.9%
2025¥259−35.1%
2024¥399+47.2%
2023¥271+61.3%
2022¥168−8.7%
2021¥184−25.5%
2020¥247−52.0%
2019¥515−22.9%
2018¥668+44.6%
2017¥462−13.8%
2016¥536−20.2%
2015¥672−34.6%
2014¥1,027−44.2%
2013¥1,840+178.4%
2012¥661−9.5%
2011¥730−20.7%
2010¥921―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2010). Please check the latest prices before trading.

CellSeed Inc. (7776) financial indicators

PBR
3.42
ROE
-68.12%
Dividend yield
0.00%

See all financial indicators for CellSeed Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of CellSeed Inc. (7776)

Business overview

Based on cell sheet engineering, a technology developed in Japan, the company aims to spread cell sheet regenerative medicine worldwide, using cell sheets to treat diseases and conditions that are hard to cure with conventional treatments. Its regenerative medicine support business researches, develops, makes and sells temperature-responsive cell culture ware, the core tool for cell sheet regenerative medicine, and related products, and provides contract regenerative medicine services. Its cell sheet regenerative medicine business is developing cell sheet regenerative medicine products and is currently preparing for commercialization.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Precision Instruments (51 companies)

PBR3.42xAbove the sector median of 1.55x (No. 43 from the lowest)
ROE-68.12%No. 46 in the sector (highest first); median 8.72%
Market cap¥6.0 bnNo. 47 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3802025/11/19
52-week low¥15311/19
Current position0.0%Where the low is 0% and the high is 100% (close on 11/19: ¥153)
Year to date-40.9%No. 50 of 51 in the sector (best first)
1 year-59.7%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/19 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (6).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the CellSeed Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English